P Tufféry - Expert opinion on drug discovery, 2015 - Taylor & Francis
Introduction: A decline in the productivity of the pharmaceutical industry research and development (R&D) pipeline has highlighted the need to reconsider the classical strategies …
A Aagaard, F Gertsen - Creativity and Innovation Management, 2011 - Wiley Online Library
This article explores how radical front end innovation is supported in pharmaceutical companies. The empirical field is an explorative case study of front end innovation in the …
The global pharmaceutical industry is facing diminishing returns from its massive investment in research and development. This is particularly troublesome because the industry has long …
A Aagaard - Systemic Practice and Action Research, 2012 - Springer
Front end innovation (FEI) represents the first building blocks of product development, but is often regarded as a weak link in innovation literature. Various theorists emphasize that a …
With an increasing amount of externally sourced innovations, a major success factor for innovation-dependent indus-tries such as the pharmaceutical industry is to successfully …
I Benali, N Acha, H Barka - Revue management & Innovation, 2021 - cairn.info
As pharmaceutical firms in Low and Middle Income Countries (LMICs) face difficulties related to Research and Development (R&D) costs, regulation, competition from imported …
Z Zhaohui, C Xiaokang - 2011 International Conference on …, 2011 - ieeexplore.ieee.org
Notice of Retraction<BR>Does R&D investment promote firms' performance? Evidence from the pharmaceutical and b Page 1 Notice of Retraction After careful and considered …
L Wang, A Plump, M Ringel - Drug discovery today, 2015 - Elsevier
Highlights•Pharmaceutical R&D is being redefined with a race to identify external innovation models.•A large diversity of models are being explored, covering the full R&D value …
A Aagaard - International Journal of Innovation Management, 2015 - World Scientific
The purpose of this paper is to explore how Front End Innovation (FEI) is supported and managed among companies of different nationality within the context of pharmaceutical …